Racial difference in endothelial function: Role of the infective burden

Atherosclerosis

Volumn 191, Issue 1, 2007, Pages 227-234

  Marchesi, Simona ^a   Lupattelli, Graziana ^a   Sensini, Alessandra ^a   Lombardini, Rita ^a   Brozzetti, Matteo ^a   Roscini, Anna Rita ^a   Siepi, Donatella ^a   Mannarino, Elmo ^a   Vaudo, Gaetano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Black race; Endothelial dysfunction; Infections; Inflammation

Indexed keywords

BACTERIUM ANTIBODY; CELL ADHESION MOLECULE; CYTOMEGALOVIRUS ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VIRUS ANTIBODY;

ADULT; AFRICA; ANTIBODY TITER; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CELL SURFACE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFLAMMATION; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; UNIVARIATE ANALYSIS; VASODILATATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHLAMYDIA INFECTIONS; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION; VIRUS DISEASES;

EID: 33846893658     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.03.029     Document Type: Article

References (44)

1. Siscovick D.S., Schwartz S.M., Corey L., et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation 102 (2000) 2335-2340
2. Ericson K., Saldeen T.G., Lindquist O., Pahlson C., and Mehta J.L. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation 101 (2000) 2568-2571
3. Ridker P.M., Hennekens C.H., Stampfer M.J., and Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 98 (1998) 2796-2799
4. Kuvin J.T., and Kimmelstiel C.D. Infectious causes of atherosclerosis. Am Heart J 137 (1999) 216-226
5. Khader Y.S., Albashaireh Z.S., and Alomari M.A. Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol 75 (2004) 1046-1053
6. Andraws R., Berger J.S., and Brown D.L. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293 (2005) 2641-2647
7. Meredith I.T., Anderson T.J., Uehata A., et al. Role of endothelium in ischemic coronary syndromes. Am J Cardiol 72 (1993) 27C-31C
8. De Caterina R., Basta G., Lazzerini G., et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17 (1997) 2646-2654
9. Vogel R.A., Corretti M.C., and Gellman J. Cholesterol, cholesterol lowering, and endothelial function. Prog Cardiovasc Dis 41 (1998) 117-136
10. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104 (2001) 191-196
11. Pistrosch F., Passauer J., Fischer S., et al. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27 (2004) 484-490
12. Corretti M.C., Plotnick G.D., and Vogel R.A. Smoking correlates with flow-mediated brachial artery vasoactivity but not cold pressor vasoactivity in men with coronary artery disease. Int J Card Imaging 14 (1998) 11-17
13. Matz R.L., and Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 20 (2003) 527-550
14. Neunteufl T., Heher S., Katzenschlager R., et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 86 (2000) 207-210
15. Heitzer T., Schlinzig T., Krohn K., et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001) 2673-2678
16. Gokce N., Keaney Jr. J.F., Hunter L.M., et al. Risk stratification for postoperative cardiovascular events via non-invasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
17. Gokce N., Keaney J.F., Hunter L.M., et al. ALSPAC (Avon Longitudinal Study of Parents and Children) Study Team. Endothelial dysfunction in childhood infection. Circulation 111 (2005) 1660-1665
18. Prasad A., Zhu J., Halcox J.P., et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106 (2002) 184-190
19. Marchesi S., Lupattelli G., Lombardini R., et al. Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis 178 (2005) 345-350
20. Kahn D.F., Duffy S.J., Tomasian D., et al. Effects of black race on forearm resistance vessel function. Hypertension 40 (2002) 195-201
21. Kalinowski L., Dobrucki I.T., and Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 109 (2004) 2511-2517
22. Marchesi S., Lupattelli G., Schillaci G., et al. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 153 (2000) 397-402
23. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
24. Kuller L.H. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 15 (2004) 109-113
25. Watkins L.O., Neaton J.D., and Kuller L.H. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 57 (1986) 538-545
26. Khalil R.A. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46 (2005) 249-254
27. The sixth report of the Joint National Committee, on prevention detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
28. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313
29. Reed W.W., and Diehl L.F. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 151 (1991) 501-505
30. Madjid M., Naghavi M., Litovsky S., and Casscells W. Influenza and cardiovascular disesease. Circulation 108 (2003) 2730-2736
31. Wolfe F., Freundlich B., and Straus W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30 (2003) 36-40
32. Jacobsen S., Petersen J., Ullman S., et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 17 (1998) 478-484
33. Elkind M.S., Cheng J., Boden-Albala B., Paik M.C., and Sacco R.L. Northern Manhattan Stroke Study. Elevated white blood cell count and carotid plaque thickness: the northern manhattan stroke study. Stroke 32 (2001) 842-849
34. Palaniappan L., Anthony M.N., Mahesh C., et al. Cardiovascular risk factors in ethnic minority women aged ≤30 years. Am J Cardiol 89 (2002) 524-529
35. Miller M.A., Sagnella G.A., Kerry S.M., et al. Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study. Clin Sci (Lond) 104 (2003) 591-598
36. Jones D.W., Chambless L.E., Folsom A.R., et al. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Arch Intern Med 162 (2002) 2565-2571
37. Calabresi L., Gomaraschi M., and Franceschini G. Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol 23 (2003) 724-731
38. Khairy P., Rinfret S., Tardif J.C., et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation 107 (2003) 1966-1971
39. Phillips J.I., Shor A., Murray J., Ong G., Taylor-, and Robinson D. Myocardial infarction associated with Chlamydia pneumoniae. Cardiovasc J S Afr 11 (2000) 25-28
40. Elkind M.S., Lin I.F., Grayston J.T., and Sacco R.L. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 31 (2000) 1521-1525
41. Lowe G.D. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 6 (2001) 1-8
42. Persson G.R., Persson R.E., Hollender L.G., and Kiyak H.A. The impact of ethnicity, gender, and marital status on periodontal and systemic health of older subjects in the Trials to Enhance Elders' Teeth and Oral Health (TEETH). J Periodontol 75 (2004) 817-823
43. Wu T.L., Tsao K.C., Chang C.P., et al. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 322 (2002) 163-168
44. Vaudo G., Marchesi S., Gerli R., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63 (2004) 31-35